Adolescent with primary cutaneous follicle center lymphoma treated with rituximab

Pediatr Blood Cancer. 2024 Apr;71(4):e30885. doi: 10.1002/pbc.30885. Epub 2024 Jan 22.

Authors

Kaitlin J Devine^{1

2}, Andrew S Freiberg³, Anne F Reilly^{1

2}

Affiliations

¹ Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
² Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
³ Pediatric Hematology/Oncology, Pennsylvania State University College of Medicine, Philadelphia, Pennsylvania, USA.

PMID: 38253812
DOI: 10.1002/pbc.30885

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Humans
Lymphoma, B-Cell* / drug therapy
Lymphoma, B-Cell* / pathology
Lymphoma, Follicular* / drug therapy
Lymphoma, Follicular* / pathology
Rituximab / therapeutic use
Skin Neoplasms* / drug therapy
Skin Neoplasms* / pathology

Substances

Rituximab